View Older Stories View More Recent Stories

Feb 29, 2024 11:43AM Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
Jan 24, 2024 07:31AM Endo International (ENDPQ) Reports Publication of New XIAFLEX Survey Data
Jan 24, 2024 07:30AM Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
Jan 22, 2024 04:31PM Endo's (ENDPQ) Paladin Labs Announces Launch of XCOPRI in Canada
Jan 22, 2024 04:30PM Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Jan 19, 2024 07:30AM Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual Meeting
Dec 19, 2023 01:30PM Endo International (ENDPQ) Files Plan of Reorganization to Implement Previously Announced Sale Transaction
Dec 19, 2023 01:27PM ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTION
Nov 30, 2023 07:30AM Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients
Nov 16, 2023 07:30AM Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
Nov 6, 2023 04:05PM ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
Nov 2, 2023 07:31AM Endo International (ENDPQ) Launches Colchicine Capsules
Nov 2, 2023 07:30AM Endo Launches Colchicine Capsules, Generic Version of MITIGARE®
Sep 21, 2023 07:45AM Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
Aug 8, 2023 07:45AM ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
Jul 20, 2023 07:30AM Endo Announces First Patient Enrolled in Registry of Peyronie's Disease
Jul 18, 2023 04:31PM Endo International (ENDPQ) Launches Bivalirudin Injection in Ready-to-Use Vials
Jul 18, 2023 04:30PM Endo Launches Bivalirudin Injection in Ready-to-Use Vials
Jul 17, 2023 04:31PM Endo International (ENDPQ) and Premier (PINC) Collaborate to Address Pitocin Shortage
Jul 17, 2023 04:30PM Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage
Jul 13, 2023 04:30PM Endo Presents New Data at the American Podiatric Medical Association Annual Meeting
Jun 29, 2023 04:30PM Endo Launches First Generic Version of Noxafil® (posaconazole) Injection
Jun 29, 2023 07:30AM Endo International (ENDPQ) Announces Approval of XCOPRI in Canada
Jun 29, 2023 07:30AM Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
Jun 26, 2023 07:30AM Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture
Jun 15, 2023 07:30AM Endo International (ENDPQ) Launches Dexlansoprazole Capsules, Generic Version of Dexilant
Jun 15, 2023 07:30AM Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®
Jun 12, 2023 07:30AM Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe
Jun 5, 2023 07:31AM Endo International (ENDPQ) Announces Publication of XIAFLEX Data Analysis
Jun 5, 2023 07:30AM Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®
May 24, 2023 07:30AM Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
May 8, 2023 07:30AM ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS
Apr 26, 2023 07:30AM Endo Announces Agreement with Slayback Pharma to Distribute Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination
Apr 17, 2023 07:45AM Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program
Apr 3, 2023 04:30PM Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension
Mar 13, 2023 04:15PM Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis
Mar 10, 2023 07:30AM Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules
Mar 6, 2023 08:50AM ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS
Feb 6, 2023 07:30AM Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease
Dec 6, 2022 04:45PM Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)
Nov 9, 2022 08:30AM ENDO REPORTS THIRD-QUARTER 2022 FINANCIAL RESULTS
Oct 27, 2022 07:30AM Endo and SMSNA Launch App to Provide Peyronie's Disease Self-Assessment Tool
Oct 7, 2022 07:30AM Endo Presents New Qwo® (collagenase clostridium histolyticum-aaes) Data at the American Society for Dermatologic Surgery's Annual Meeting
Oct 5, 2022 07:30AM Endo Launches Unscripted Video Series With Real Dupuytren's Contracture Patients
View More Recent Stories View Older Stories